Immunofluorescence (IF) staining verified a substantial KD of FGFR2 or CD44 following oral administration of Dox during tumor growth in tumor cell-injected mice and a subsequent delay in tumor growth (Figure 1D right and E right, respectively). This evidence concerns the gene CD44 and neoplasm.